Search

Search Constraints

You searched for: Author/Creator Gordon, Mark Forrest

Search Results

1. 151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study. (April 2020)

2. 152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents. (April 2020)

3. [P4–014]: THE COALITION AGAINST MAJOR DISEASES: TOWARD U.S. FDA QUALIFICATION OF HIPPOCAMPAL VOLUME AS A BIOMARKER FOR ENRICHMENT IN CLINICAL TRIALS FOR PRE‐DEMENTIA STAGES OF ALZHEIMER'S DISEASE. (1st July 2017)

5. [P4–341]: LEVELS OF BLOOD PRESSURE, BODY MASS INDEX AND TOTAL SERUM CHOLESTEROL AT DIFFERENT TIME POINTS PRIOR TO DEMENTIA DIAGNOSIS: A CASE CONTROL STUDY OF OVER 28 MILLION ELECTRONIC HEALTH RECORDS FROM THE EMIF EHR DATA RESOURCE. (1st July 2017)

6. A PET-CT study on neuroinflammation in Huntington's disease patients participating in a randomized trial with laquinimod. Issue 2 (3rd April 2023)

8. Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge. Issue 9 (27th May 2016)

9. Clinically Meaningful Outcomes in Early Alzheimer Disease: A Consortia-Driven Approach to Identifying What Matters to Patients. (May 2017)